Tecovirimat is highly efficient on the Monkeypox virus lineage responsible for the international 2022 outbreak
G. Frenois-Veyrat, F. Gallardo, O. Gorge, E. Marcheteau, O. Ferraris, A. Baidaliuk, A.-L. Favier, C. Enfroy, X. Holy, J. Lourenco, R. Khoury, F. Nolent, D. W. Grosenbach, D. Hruby, A. Ferrier, , J.-N. Tournier
This study tests tecovirimat's efficacy against the 2022 MPXV outbreak strain, showing nanomolar activity compared to cidofovir's micromolar activity.
bioRxiv · Jul 19, 2022 · PreprintMicrobiology